Bredt David

Chief Scientific Officer

Bredt David has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Feb 19, 2026.

On the most recent filing, Bredt David is listed as Chief Scientific Officer at Rapport Therapeutics, Inc. Inside the rolling window, Bredt David reported no open-market purchases and 6 open-market sales totaling $1.4M in RAPP. The largest disclosed transaction in the window is a sale of 8,500 RAPP shares on Dec 15, 2025, worth $255K.

Companies traded

Other insiders at RAPP

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
RAPPSale$247KFeb 19SEC ↗
RAPPSale$228KJan 16SEC ↗
RAPPSale$197KJan 5SEC ↗
RAPPSale$255KDec 16SEC ↗
RAPPSale$214KNov 18SEC ↗
RAPPSale$219KOct 16SEC ↗
Showing 1–6 of 6
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 15, 2025RAPPSale$84K
Sep 15, 2025RAPPSale$122K
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Bredt David made?

Bredt David has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.

Which companies does Bredt David trade?

Bredt David has filed SEC Form 4 disclosures for 1 company, including RAPP.

When was Bredt David's most recent SEC Form 4 filing?

Bredt David's most recent SEC Form 4 filing on Tracefour is dated Feb 19, 2026.

What is Bredt David's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Bredt David is listed as Chief Scientific Officer.

What is Bredt David's total buy and sell value in the current window?

Inside the rolling retention window, Bredt David bought $0 and sold $1.4M based on SEC Form 4 filings.

What was Bredt David's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 8,500 RAPP shares on 2025-12-15, worth $255K, per SEC Form 4 filings.